tiprankstipranks
Immunovant (IMVT)
NASDAQ:IMVT
Holding IMVT?
Track your performance easily

Immunovant (IMVT) Technical Analysis

762 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
1Neutral
14Bearish
Technical Analysis Consensus
Buy
7Bullish
1Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Immunovant’s (IMVT) Moving Averages Convergence Divergence (MACD) indicator is -0.81, suggesting Immunovant is a Buy.
Immunovant’s (IMVT) 20-Day exponential moving average is 28.68, while Immunovant’s (IMVT) share price is $26.17, making it a Sell.
Immunovant’s (IMVT) 50-Day exponential moving average is 29.24, while Immunovant’s (IMVT) share price is $26.17, making it a Sell.

Immunovant (IMVT) Pivot Points

Nov 21, 2024, 08:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
23.07
24.16
24.83
25.92
26.59
27.68
28.35
Fibonacci
24.16
24.83
25.24
25.92
26.59
27.00
27.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunovant (IMVT) Moving Averages

Nov 21, 2024, 08:17 AM
Period
Simple
Exponential
MA5
26.86Sell
26.67Sell
MA10
28.67Sell
27.82Sell
MA20
29.29Sell
28.68Sell
MA50
29.24Sell
29.24Sell
MA100
29.45Sell
29.63Sell
MA200
30.03Sell
31.34Sell
Immunovant’s (IMVT) 10-Day exponential moving average is 27.82, while Immunovant’s (IMVT) share price is $26.17, making it a Sell.
Immunovant’s (IMVT) 100-Day exponential moving average is 29.63, while Immunovant’s (IMVT) share price is $26.17, making it a Sell.
Immunovant’s (IMVT) stock price is $26.17 and Immunovant’s (IMVT) 50-day simple moving average is 29.24, creating a Sell signal.
Immunovant’s (IMVT) stock price is $26.17 and Immunovant’s (IMVT) 100-day simple moving average is 29.45, creating a Sell signal.
Immunovant’s (IMVT) stock price is $26.17 and Immunovant’s (IMVT) 200-day simple moving average is 30.03, creating a Sell signal.

Immunovant (IMVT) Technical Indicators

Nov 21, 2024, 08:17 AM
Name
Value
Implied Action
RSI (14)
29.78
Buy
STOCH (9,6)
5.48
Buy
STOCHRSI (14)
5.32
Buy
MACD (12,26)
-0.81
Buy
ADX (14)
17.90
Buy
Williams %R
-91.86
Buy
CCI (14)
-250.35
Buy
ATR (14)
1.34
-
Ultimate Oscillator
30.25
Neutral
ROC
-16.43
Sell
Immunovant’s (IMVT) Relative Strength Index (RSI) is 29.78, creating a Buy signal.
Immunovant’s (IMVT) Trend Strength Indicator (ADX) is 17.90, creating a Buy signal.
Immunovant’s (IMVT) Commodity Channel Index (CCI) is -250.35, creating a Buy signal.
Immunovant’s (IMVT) Price Rate of Change (ROC) is -16.43, creating a Sell signal.

FAQ

Is IMVT a Buy, Hold, or Sell?
Based on IMVT’s technical indicators, IMVT is a Sell.
    What is IMVT’s RSI (14)?
    IMVT’s RSI (14) is 29.78, which suggests IMVT is a Buy.
      What is IMVT’s MACD?
      IMVT’s MACD is -0.81, which suggests IMVT is a Buy.
        What is IMVT’s 5-day moving average?
        IMVT’s 5-day moving average is 26.86, which suggests IMVT is a Sell.
          What is IMVT’s 20-day moving average?
          IMVT 20-day moving average is 29.29, which suggests IMVT is a Sell.
            What is IMVT’s 50-day moving average?
            IMVT’s 50-day moving average is 29.24, which suggests IMVT is a Sell.
              What is IMVT’s 200-day moving average?
              IMVT’s 200-day moving average is 30.03, which suggests IMVT is a Sell.
                What is IMVT’s Williams % R (14)?
                IMVT’s Williams % R (14) is -91.86, which suggests IMVT is a Buy.
                  What is IMVT’s CCI (14)?
                  IMVT’s CCI (14) is -250.35, which suggests IMVT is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis